Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. K-strophanthin-beta
2. Kombetin
3. Strophosid
1. Beta-k-strophanthin
2. 560-53-2
3. K-strophanthin-beta
4. Strophanthin
5. K935s3t1oe
6. Chebi:80753
7. Nsc-4320
8. (3s,5s,8r,9s,10s,13r,14s,17r)-5,14-dihydroxy-3-[(2r,4s,5r,6r)-4-methoxy-6-methyl-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-13-methyl-17-(5-oxo-2h-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene-10-carbaldehyde
9. Nsc 4320
10. Strophanthidin-glucocymarosid
11. Strophosid
12. Nsc-7670
13. Einecs 209-210-9
14. Strophanthidin-glucocymarosid [german]
15. Brn 0076510
16. Beta-strophanthobioside, Strophanthidin-3
17. Strophantin K (mixture)
18. Unii-k935s3t1oe
19. Chembl540506
20. Schembl6940151
21. Dtxsid00971387
22. Card-20(22)-enolide, 3-((2,6-dideoxy-4-o-.beta.-d-glucopyranosyl-3-o-methyl-.beta.-d-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3.beta.,5.beta.)-
23. Zinc85902168
24. (3beta,5beta)-3-((2,6-dideoxy-4-o-beta-d -glucopyranosyl-3-o-methyl-beta-d -ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxocard-20(22)-enolide
25. 5-beta-card-20(22)-enolide, 3-beta-((2,6-dideoxy-4-o-beta-d-glucopyranosyl-3-o-methyl-beta-d-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-
26. K-strophanthin-beta; Card-20(22)-enolide, 3-((2,6-dideoxy-4-o-beta-d-glucopyranosyl-3-o-methyl-beta-d-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)-
27. 5-18-05-00132 (beilstein Handbook Reference)
28. Q27149806
Molecular Weight | 710.8 g/mol |
---|---|
Molecular Formula | C36H54O14 |
XLogP3 | -0.8 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 8 |
Exact Mass | 710.35135639 g/mol |
Monoisotopic Mass | 710.35135639 g/mol |
Topological Polar Surface Area | 211 Ų |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Complexity | 1330 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 17 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Global Sales Information
Market Place
ABOUT THIS PAGE
59
PharmaCompass offers a list of K-Strophanthin-Beta API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right K-Strophanthin-Beta manufacturer or K-Strophanthin-Beta supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred K-Strophanthin-Beta manufacturer or K-Strophanthin-Beta supplier.
PharmaCompass also assists you with knowing the K-Strophanthin-Beta API Price utilized in the formulation of products. K-Strophanthin-Beta API Price is not always fixed or binding as the K-Strophanthin-Beta Price is obtained through a variety of data sources. The K-Strophanthin-Beta Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A K-Strophanthin-Beta manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of K-Strophanthin-Beta, including repackagers and relabelers. The FDA regulates K-Strophanthin-Beta manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. K-Strophanthin-Beta API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A K-Strophanthin-Beta supplier is an individual or a company that provides K-Strophanthin-Beta active pharmaceutical ingredient (API) or K-Strophanthin-Beta finished formulations upon request. The K-Strophanthin-Beta suppliers may include K-Strophanthin-Beta API manufacturers, exporters, distributors and traders.
K-Strophanthin-Beta Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of K-Strophanthin-Beta GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right K-Strophanthin-Beta GMP manufacturer or K-Strophanthin-Beta GMP API supplier for your needs.
A K-Strophanthin-Beta CoA (Certificate of Analysis) is a formal document that attests to K-Strophanthin-Beta's compliance with K-Strophanthin-Beta specifications and serves as a tool for batch-level quality control.
K-Strophanthin-Beta CoA mostly includes findings from lab analyses of a specific batch. For each K-Strophanthin-Beta CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
K-Strophanthin-Beta may be tested according to a variety of international standards, such as European Pharmacopoeia (K-Strophanthin-Beta EP), K-Strophanthin-Beta JP (Japanese Pharmacopeia) and the US Pharmacopoeia (K-Strophanthin-Beta USP).